• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Glob Health . COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023

tetano

Editor, Senior Moderator
BMJ Glob Health


. 2026 Feb 17;11(2):e020513.
doi: 10.1136/bmjgh-2025-020513.
COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023 to 2024

Julie Garon Carlton[SUP] 1 [/SUP], Eva Bazant[SUP] 2 [/SUP], Chelsey Griffin[SUP] 3 [/SUP], Katharine M Cooley[SUP] 3 [/SUP], Hongjiang Gao[SUP] 4 [/SUP], Margaret McCarron[SUP] 3 [/SUP], Ahamed Khairul Basher[SUP] 5 [/SUP], Ummi Rukaiya Munni[SUP] 5 [/SUP], Daouda Coulibaly[SUP] 6 [/SUP], Collins Ahorlu[SUP] 7 [/SUP], Chansay Pathammavong[SUP] 8 [/SUP], Phonethipsavanh Nouanthong[SUP] 9 [/SUP], Zeina Farah[SUP] 10 [/SUP], Mohammed Ismaili Alaoui[SUP] 11 [/SUP], Mouad Merabet[SUP] 11 [/SUP], Jeriel Reyes De Silos[SUP] 12 [/SUP], Clyde E Silverio[SUP] 13 [/SUP], Prabda Praphasiri[SUP] 14 15 [/SUP], Darunee Ditsungnoen[SUP] 15 [/SUP], Aicha Hechaichi[SUP] 16 [/SUP], Fatma Ben Youssef[SUP] 16 [/SUP], Joseph S Bresee[SUP] 2 [/SUP], Ann Moen[SUP] 17 18 [/SUP], Jaymin C Patel[SUP] 4 [/SUP]


Affiliations
Free article Abstract

Introduction: Health workers (HWs) set an example for vaccine recipients, convey vaccine benefits and risks and interface with patients at increased risk for complications in pandemic settings. We explored HWs' acceptance of and recommendation for COVID-19 vaccine with and without previous receipt of seasonal influenza vaccine (SIV) in nine countries.
Methods: In 2023-2024, cross-sectional surveys among HW were conducted in Bangladesh, Cote d'Ivoire, Ghana, Laos, Lebanon, Morocco, Philippines, Thailand and Tunisia. Country researchers used a standard protocol and questionnaire to assess beliefs, perceptions and acceptance around SIV and COVID-19 vaccine and likelihood of recommending these vaccines to patients. Pooled findings were stratified by the presence or absence of a national HW SIV recommendation. Generalised mixed effects models were used to characterise the relationship between receipt of SIV and COVID-19 vaccine acceptance and recommendation, adjusting for WHO region, sex and duration of employment.
Results: Our analysis included 12 296 HWs from nine countries representing four WHO regions: African, Eastern Mediterranean, Southeast Asian and Western Pacific. Five countries had a national HW SIV recommendation (61% of HWs surveyed) prior to COVID-19 vaccine introduction. More than 90% of HWs reported completing the COVID-19 vaccination series, whereas intention to continue receiving annual COVID-19 vaccine was lower (61%). HWs who received SIV in the last season compared with those who did not were more likely to have received one or more COVID-19 booster doses (adjusted OR (aOR) 2.63, 95% CI 2.27 to 3.04) and to have recommended COVID-19 vaccine to patients (aOR 1.53, 95% CI 1.29 to 1.82).
Conclusions: Prior experience with SIV was associated with HW behaviour and recommendations regarding COVID-19 vaccination. Intention to continue receiving COVID-19 vaccines remains a challenge; ongoing training and education for vaccination staff could be beneficial. HWs play a critical role in the successful delivery of new and existing vaccines, particularly in a pandemic setting.

Keywords: COVID-19; Global Health; Health Personnel; Vaccines.

 
Back
Top Bottom